| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 0.02 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.17 | 0.3 |